Skip to content
JLM-BioCity
  • HOME
  • ABOUT US
    • What is JLM-BioCity?
    • What We Do
    • Board of Advisors
    • Meet the Team
  • EVENTS
    • Past Events
    • Event Clips
  • RESOURCES
    • JLM BIO INNOVATION
    • JLM COMPANIES
    • JLM LANDSCAPE
    • BIOTIPS
    • BLOG
    • BRIEFS
  • JOIN US
    • Our Partners
    • Become a Partner
  • JLM-BIOSYNERGY
  • CONTACT US
Menu Close
  • HOME
  • ABOUT US
    • What is JLM-BioCity?
    • What We Do
    • Board of Advisors
    • Meet the Team
  • EVENTS
    • Past Events
    • Event Clips
  • RESOURCES
    • JLM BIO INNOVATION
    • JLM COMPANIES
    • JLM LANDSCAPE
    • BIOTIPS
    • BLOG
    • BRIEFS
  • JOIN US
    • Our Partners
    • Become a Partner
  • JLM-BIOSYNERGY
  • CONTACT US

JLM-BioCity Innovations

  1. Home>
  2. Resources>
  3. JLM-BioCity Innovations>
  4. Page 26
Entera Bio is a product-focused biotechnology company specializing in the oral delivery of large molecules and biologics

Positive results in Entera Bio’s pharmacokinetic (PK) & pharmacodynamic (PD) study in patients with hypoparathyroidism

November 25, 2018

Entera Bio Ltd. (Nasdaq: ENTX) announced today that it has received positive results from the first part of its pharmacokinetic (PK) and pharmacodynamic (PD) study in

Read More »
JLM-BioCIty pharma biotech flu influenza vaccine

The New Scientist Reports on Biondvax’s Universal Flu Vaccine

November 17, 2018

For decades, scientists have been trying to develop a universal vaccine that would protect people against seasonal flu for years, and also against pandemics, which

Read More »
JLM-BioCity pharma Bladder cancer

Anchiano Therapeutics files for $30-40m Nasdaq offering

November 17, 2018

Jerusalem based cancer treatment company Anchiano Therapeutics (TASE: ANCN), formerly BioCancell Therapeutics, has announced the publication of a confidential prospectus for an offering on Nasdaq. It is

Read More »
JLM-BioCity Biotech Pharma

Results of Zion Medical’s First Human Clinical Trial of HIV drug Gammora Offers Potential Cure

November 11, 2018

Zion Medical, an Israeli biotech company developing HIV and cancer treatments, has announced the results of the first clinical trial of HIV-drug Gammora, eliminating up

Read More »
|JLM-BIOCITY pharma Hebrew University

Hebrew U Researchers Develop Technology for 3-D Printing of Drugs

November 11, 2018

Researchers from Jerusalem’s Hebrew University unveiled their novel technology for three-dimensional printing of drug capsules on Wednesday, enabling the customization and personalization of medications unavailable

Read More »
JLM-BioCITY Biotech stem cells

JLM-based Gamida Cell to raise $69m in Nasdaq IPO/adds Robert Blum as new Chairman of the Board

November 11, 2018

Jerusalem stem cell cancer therapy developer Gamida Cell Ltd. has filed a registration statement on Form F-1 with the US Securities and Exchange Commission (SEC)

Read More »
Argaman-feelament

CDC sponsored study: Argaman Technologies reduced by 25% hospital acquired infections and by 40% Multi-Drug Resistant Organisms in Wards!

October 4, 2018

The University of Pennsylvania Medical School Hospital is to announce the results of a study on the impact of Argaman Technologies in a hospital at the

Read More »
JLM-BioCity Biomed dental

Densys3D Announces US Dental Depot as Regional US Distributor

October 4, 2018

 Densys3d has entered into a strategic agreement with US Dental Depot as a regional distributor for their intraoral scanner, MIA3D software, and speed scanner spray. This

Read More »

Hadassah Hebrew U BioDesign Project, CardioVia, Raises NIS 3 Million & Was Accepted to the NGT3 VC Incubator

September 21, 2018

Following the June 2018 presentation of bio-med projects in the framework of the BioDesign, a joint program of  Hadassah Medical Center and the Hebrew University

Read More »
« Previous Page1 Page2 Page3 Page4 Page5 Page6 Page7 Page8 Page9 Page10 Page11 Page12 Page13 Page14 Page15 Page16 Page17 Page18 Page19 Page20 Page21 Page22 Page23 Page24 Page25 Page26 Page27 Page28 Page29 Page30 Page31 Page32 Page33 Page34 Page35 Page36 Page37 Page38 Page39 Next »

JLM-BioCity Upcoming Events

JLM-BioCity-&-Columbia-Mission-2022a
To RSVP, contact Sara Gdanski, JLM-BioCity Corporate Relations Manager at 058-7922882
or email her at: sara.gdanski1 AT gmail.com

More JLM BioCity events coming soon…

What people are saying…

Moshe Lebowitz with Jerusalem Mayor Moshe Leon - Credit Dr George Lowell

Because every biotech and medtech professional knows that Jerusalem BioCity consistently delivers world-class programming, the best professionals always show up and the networking before and after the events is worth its time in gold.

- Moshe Lebowitz, CEO, Healables Digital Health | Healables: Wearables that Heal

Ian Solomon CTO, OmnySense Ltd

The JLM Biocity networking events on Zoom keeps getting better.  For OmnySense they have provided an excellent forum in which to present our company, and the break-out sessions facilitate direct discussion with a broad range of potential partners and investors.

- Ian Solomon CTO, OmnySense Ltd.

Dror Chevion Concenter BioPharma

JLM-BioCity's events are well organized with a professional approach. You can feel a "homey" atmosphere around the people of a well-maintained bio-community in Jerusalem. Team members always make sure the guests feel welcome and connected to the right people for possible collaborations. There are clearly visible good-will and dedication to lead the members of the bio-community and the city as a whole to success.

- Dror Chevion CEO, Concenter BioPharma

Immanuel Lerner CEO, Pepticom

I believe in the idea of JLM-BioCity. It is good that there is an organization that represents the life science companies in Jerusalem and provides an excellent platform for networking through its regular meetings.

- Immanuel Lerner CEO, Pepticom

JLM BioCity Member Gideon Silberman

Excellent event. Good speakers, interesting audience. Well done!

- Gideon Silberman, Director of Business Development, Partner and Co-Founder, Aneeva.com

JLM-BioCity member Zeev Malyutin

Thank you all for the great evening, it was a pleasure to see such a good and diverse set of Biomed minded people in Jerusalem!

- Zeev Malyutin, Protein Department Head, Merck KGaA

JLM-BioCity member Aurélie Schwarzbach

Such an interesting lecture and great people attending!

- Aurélie Schwarzbach, Clinical Project Manager, Gamida Cell Ltd.

JLM-BioCity member Jonathan Miller

Interesting - I could see it helping people network - a good thing!

- Jonathan Miller, Founder, President, and Designer, U-Step, Neurological Walking Aids

JLM BioCity Member Yael Ophir

Great atmosphere, great people.

- Yael Ophir, Executive Director, HealthIL

JLM BioCity Member Aviv Marom

There was an excellent networking atmosphere with impressive Panelists as well as high-quality audience participants. I strongly recommend paying attention to future events.

Aviv Marom, Director, Strategic Partnerships, Samsung Research, Israel

JLM BioCity Member Hemda Idel

Very informative and eye-opening event. Thank you for the great hospitality.

- Hemda Idel, founder, SLEEP ASAP

JLM-BioCity Member Tal Or

one of the best meetups organizations and a very important source of information and connections for startups.

Tal Or, Co-Founder, ATLASense Biomed Ltd.

JLM-BioCity Member Alexander Naslednikov

Excellent organization (from the timing to food), the quality of the audience was superior, we personally got a lot of hot leads.

Alexander Naslednikov, Founder and CEO, Med.me

<< Prev
Next >>

JLM-BioCity in THE MARKER

JLM-BioCity was recently written up in THE MARKER (in Hebrew). To see the article, click here.

Strategic Partners

Platinum

Gold

Silver

JLM-BIOCITY is a division of the Jerusalem Business Networking Forum (JBNF)

Contact us at

+972-(0)54-973-0029

info at jlm-biocity.org

Follow us

Linkedin Facebook-f Youtube

Home

About

What’s Happening

Resources

Become a Partner

Become a Member

JLM-BioSynergy

Contact Us

Copyright © 2020 JLM-BioCity | All rights reserved